IMP
Process View
cellular hormone metabolic process
The chemical reactions and pathways involving any hormone, naturally occurring substances secreted by specialized cells that affects the metabolism or behavior of other cells possessing functional receptors for the hormone, as carried out by individual cells.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "cellular hormone metabolic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| AKR1C2 | aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III) | 0.998 | ||
| SULT1A1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 | 0.970 | ||
| SULT1A2 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 | 0.957 | Human Rat | |
| AKR1C1 | aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase) | 0.956 | ||
| SULT1A4 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4 | 0.920 | Human Rat | |
| MPDZ | multiple PDZ domain protein | 0.881 | ||
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.807 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.781 | ||
| AKR1C3 | aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) | 0.744 | ||
| IL1R1 | interleukin 1 receptor, type I | 0.691 | ||
| CREBBP | CREB binding protein | 0.595 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.567 | ||
| ALS2CR12 | amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 12 | 0.535 | ||
| ALDH1A1 | aldehyde dehydrogenase 1 family, member A1 | 0.463 | Human Mouse Rat | |
| TTR | transthyretin | 0.397 | ||
| ALDH2 | aldehyde dehydrogenase 2 family (mitochondrial) | 0.363 | Human | |
| BMPR1B | bone morphogenetic protein receptor, type IB | 0.356 | ||
| CAT | catalase | 0.333 | ||
| ESRRG | estrogen-related receptor gamma | 0.290 | ||
| NF2 | neurofibromin 2 (merlin) | 0.178 | ||
| NOG | noggin | 0.175 | ||
| MYO6 | myosin VI | 0.173 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.168 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.164 | ||
| IL1RAP | interleukin 1 receptor accessory protein | 0.158 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.132 | ||
| ADH1C | alcohol dehydrogenase 1C (class I), gamma polypeptide | 0.116 | ||
| TUBB8 | tubulin, beta 8 | 0.111 | ||
| SH3BGRL | SH3 domain binding glutamic acid-rich protein like | 0.103 | ||
| NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.100 | ||
| HTR2C | 5-hydroxytryptamine (serotonin) receptor 2C | 0.095 | ||
| FSTL1 | follistatin-like 1 | 0.093 | ||
| AR | androgen receptor | 0.086 | ||
| INSR | insulin receptor | 0.084 | ||
| MED10 | mediator complex subunit 10 | 0.084 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.075 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.074 | ||
| CAV2 | caveolin 2 | 0.073 | ||
| HSD17B4 | hydroxysteroid (17-beta) dehydrogenase 4 | 0.070 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.069 | ||
| SULT1E1 | sulfotransferase family 1E, estrogen-preferring, member 1 | 0.068 | ||
| RARA | retinoic acid receptor, alpha | 0.068 | ||
| CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 0.067 | ||
| SULT2B1 | sulfotransferase family, cytosolic, 2B, member 1 | 0.066 | Human | |
| FGF18 | fibroblast growth factor 18 | 0.064 | ||
| PDGFC | platelet derived growth factor C | 0.061 | ||
| WNT4 | wingless-type MMTV integration site family, member 4 | 0.061 | ||
| WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.060 | ||
| AADAC | arylacetamide deacetylase (esterase) | 0.058 | ||
| STAT5A | signal transducer and activator of transcription 5A | 0.057 | ||
| TG | thyroglobulin | 0.056 | ||
| ANXA4 | annexin A4 | 0.056 | ||
| CYP3A43 | cytochrome P450, family 3, subfamily A, polypeptide 43 | 0.056 | Fly | |
| IGSF21 | immunoglobin superfamily, member 21 | 0.056 | ||
| NCOA3 | nuclear receptor coactivator 3 | 0.055 | ||
| MED13 | mediator complex subunit 13 | 0.054 | ||
| IDH1 | isocitrate dehydrogenase 1 (NADP+), soluble | 0.054 | ||
| MAPK15 | mitogen-activated protein kinase 15 | 0.052 | ||
| PTPN13 | protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) | 0.051 | ||
| UGT2B15 | UDP glucuronosyltransferase 2 family, polypeptide B15 | 0.050 | Human | |
| DECR1 | 2,4-dienoyl CoA reductase 1, mitochondrial | 0.050 | ||
| NR1I2 | nuclear receptor subfamily 1, group I, member 2 | 0.049 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.049 | ||
| MMP11 | matrix metallopeptidase 11 (stromelysin 3) | 0.048 | ||
| HSD3B2 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | 0.046 | Rat | |
| MTHFD1 | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase | 0.045 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.045 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.043 | ||
| C2orf18 | chromosome 2 open reading frame 18 | 0.042 | ||
| ADH1A | alcohol dehydrogenase 1A (class I), alpha polypeptide | 0.040 | Human | |
| C8A | complement component 8, alpha polypeptide | 0.039 | ||
| PROX1 | prospero homeobox 1 | 0.037 | ||
| SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.037 | ||
| KNG1 | kininogen 1 | 0.036 | ||
| DDX17 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 17 | 0.035 | ||
| UGT2B17 | UDP glucuronosyltransferase 2 family, polypeptide B17 | 0.034 | Human | |
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.034 | ||
| LAMP2 | lysosomal-associated membrane protein 2 | 0.033 | ||
| WNT1 | wingless-type MMTV integration site family, member 1 | 0.033 | Human | |
| ACACA | acetyl-CoA carboxylase alpha | 0.033 | ||
| GADD45G | growth arrest and DNA-damage-inducible, gamma | 0.033 | ||
| THRA | thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) | 0.033 | ||
| PRMT2 | protein arginine methyltransferase 2 | 0.033 | ||
| FGF4 | fibroblast growth factor 4 | 0.032 | ||
| OTC | ornithine carbamoyltransferase | 0.032 | ||
| PAFAH1B3 | platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa) | 0.032 | ||
| SLC17A1 | solute carrier family 17 (sodium phosphate), member 1 | 0.032 | ||
| WIF1 | WNT inhibitory factor 1 | 0.031 | ||
| GABRA3 | gamma-aminobutyric acid (GABA) A receptor, alpha 3 | 0.031 | ||
| WNT11 | wingless-type MMTV integration site family, member 11 | 0.031 | Human | |
| UROD | uroporphyrinogen decarboxylase | 0.031 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.031 | ||
| NDRG1 | N-myc downstream regulated 1 | 0.030 | ||
| SLC2A2 | solute carrier family 2 (facilitated glucose transporter), member 2 | 0.030 | ||
| MASP1 | mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | 0.029 | ||
| ALDOB | aldolase B, fructose-bisphosphate | 0.029 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.029 | ||
| KANK2 | KN motif and ankyrin repeat domains 2 | 0.029 | ||
| DLX4 | distal-less homeobox 4 | 0.029 | ||
| PGCP | plasma glutamate carboxypeptidase | 0.028 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.028 | ||
| MED6 | mediator complex subunit 6 | 0.027 | ||
| HNMT | histamine N-methyltransferase | 0.026 | ||
| NAT2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) | 0.026 | ||
| ALDH3A2 | aldehyde dehydrogenase 3 family, member A2 | 0.026 | ||
| SLC10A1 | solute carrier family 10 (sodium/bile acid cotransporter family), member 1 | 0.026 | ||
| CYP3A4 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 0.026 | Fly | |
| SEPP1 | selenoprotein P, plasma, 1 | 0.025 | ||
| FBLN1 | fibulin 1 | 0.025 | ||
| SREBF2 | sterol regulatory element binding transcription factor 2 | 0.025 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.025 | ||
| RXRA | retinoid X receptor, alpha | 0.025 | ||
| ST8SIA2 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 | 0.025 | ||
| RNASE4 | ribonuclease, RNase A family, 4 | 0.025 | ||
| CRP | C-reactive protein, pentraxin-related | 0.024 | ||
| HPX | hemopexin | 0.024 | ||
| FZD10 | frizzled homolog 10 (Drosophila) | 0.024 | ||
| TM4SF4 | transmembrane 4 L six family member 4 | 0.024 | ||
| BMP7 | bone morphogenetic protein 7 | 0.024 | Human | |
| AQP5 | aquaporin 5 | 0.024 | ||
| CD302 | CD302 molecule | 0.024 | ||
| PAH | phenylalanine hydroxylase | 0.024 | ||
| FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.023 | ||
| HPD | 4-hydroxyphenylpyruvate dioxygenase | 0.023 | ||
| ADD3 | adducin 3 (gamma) | 0.023 | ||
| HRG | histidine-rich glycoprotein | 0.023 | ||
| ADH6 | alcohol dehydrogenase 6 (class V) | 0.023 | Human | |
| HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) | 0.022 | ||
| TTPA | tocopherol (alpha) transfer protein | 0.022 | ||
| PCDHA4 | protocadherin alpha 4 | 0.022 | ||
| LRP6 | low density lipoprotein receptor-related protein 6 | 0.022 | ||
| PAPPA | pregnancy-associated plasma protein A, pappalysin 1 | 0.022 | ||
| CYP2A6 | cytochrome P450, family 2, subfamily A, polypeptide 6 | 0.021 | ||
| NR1I3 | nuclear receptor subfamily 1, group I, member 3 | 0.021 | ||
| MITF | microphthalmia-associated transcription factor | 0.021 | ||
| FOXE1 | forkhead box E1 (thyroid transcription factor 2) | 0.021 | ||
| NNT | nicotinamide nucleotide transhydrogenase | 0.021 | ||
| FOXC2 | forkhead box C2 (MFH-1, mesenchyme forkhead 1) | 0.020 | ||
| SOX1 | SRY (sex determining region Y)-box 1 | 0.020 | ||
| DIO1 | deiodinase, iodothyronine, type I | 0.020 | ||
| ACADM | acyl-CoA dehydrogenase, C-4 to C-12 straight chain | 0.020 | ||
| ASAH1 | N-acylsphingosine amidohydrolase (acid ceramidase) 1 | 0.020 | ||
| HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.020 | ||
| ANGPTL3 | angiopoietin-like 3 | 0.020 | ||
| IHH | Indian hedgehog | 0.020 | ||
| EFNB3 | ephrin-B3 | 0.020 | ||
| ADH1B | alcohol dehydrogenase 1B (class I), beta polypeptide | 0.020 | Human | |
| GRIN2C | glutamate receptor, ionotropic, N-methyl D-aspartate 2C | 0.020 | ||
| SCP2 | sterol carrier protein 2 | 0.020 | ||
| CDX1 | caudal type homeobox 1 | 0.020 | ||
| TGS1 | trimethylguanosine synthase 1 | 0.019 | ||
| ITM2B | integral membrane protein 2B | 0.019 | ||
| GRP | gastrin-releasing peptide | 0.019 | ||
| TM4SF5 | transmembrane 4 L six family member 5 | 0.019 | ||
| BHMT | betaine--homocysteine S-methyltransferase | 0.019 | ||
| ZEB2 | zinc finger E-box binding homeobox 2 | 0.019 | ||
| RYBP | RING1 and YY1 binding protein | 0.019 | ||
| ZC3H13 | zinc finger CCCH-type containing 13 | 0.019 | ||
| G6PC | glucose-6-phosphatase, catalytic subunit | 0.019 | ||
| SH3BP4 | SH3-domain binding protein 4 | 0.018 | ||
| CYP2C18 | cytochrome P450, family 2, subfamily C, polypeptide 18 | 0.018 | ||
| HOXB1 | homeobox B1 | 0.018 | ||
| GLYAT | glycine-N-acyltransferase | 0.018 | ||
| ELF1 | E74-like factor 1 (ets domain transcription factor) | 0.018 | ||
| TFPI | tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | 0.018 | ||
| PTGER3 | prostaglandin E receptor 3 (subtype EP3) | 0.018 | ||
| NR1H4 | nuclear receptor subfamily 1, group H, member 4 | 0.018 | ||
| ARID1A | AT rich interactive domain 1A (SWI-like) | 0.018 | ||
| ARL6IP5 | ADP-ribosylation-like factor 6 interacting protein 5 | 0.018 | ||
| ENPP1 | ectonucleotide pyrophosphatase/phosphodiesterase 1 | 0.018 | ||
| SUCLG2 | succinate-CoA ligase, GDP-forming, beta subunit | 0.018 | ||
| SERPINA4 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 | 0.018 | ||
| WNT3 | wingless-type MMTV integration site family, member 3 | 0.018 | Human | |
| APOA2 | apolipoprotein A-II | 0.018 | ||
| NCOA4 | nuclear receptor coactivator 4 | 0.018 | ||
| CYP4F11 | cytochrome P450, family 4, subfamily F, polypeptide 11 | 0.018 | ||
| EDN3 | endothelin 3 | 0.018 | ||
| FGF3 | fibroblast growth factor 3 | 0.018 | ||
| ROR2 | receptor tyrosine kinase-like orphan receptor 2 | 0.017 | ||
| SULT1B1 | sulfotransferase family, cytosolic, 1B, member 1 | 0.017 | Human | |
| PLIN1 | perilipin 1 | 0.017 | ||
| COL4A6 | collagen, type IV, alpha 6 | 0.017 | ||
| CYP19A1 | cytochrome P450, family 19, subfamily A, polypeptide 1 | 0.017 | ||
| WNT6 | wingless-type MMTV integration site family, member 6 | 0.017 | Human | |
| FOXA2 | forkhead box A2 | 0.017 | ||
| EHHADH | enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase | 0.017 | ||
| MYOC | myocilin, trabecular meshwork inducible glucocorticoid response | 0.017 | ||
| SLC6A4 | solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 | 0.017 | ||
| WNT10A | wingless-type MMTV integration site family, member 10A | 0.017 | Human | |
| PITX2 | paired-like homeodomain 2 | 0.017 | ||
| ALOX15B | arachidonate 15-lipoxygenase, type B | 0.017 | ||
| PRLR | prolactin receptor | 0.017 | ||
| APOC3 | apolipoprotein C-III | 0.017 | ||
| SMAD6 | SMAD family member 6 | 0.017 | ||
| CSNK1D | casein kinase 1, delta | 0.016 | ||
| FABP1 | fatty acid binding protein 1, liver | 0.016 | ||
| SRI | sorcin | 0.016 | ||
| SERPINA3 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 | 0.016 | ||
| APCS | amyloid P component, serum | 0.016 | ||
| NQO1 | NAD(P)H dehydrogenase, quinone 1 | 0.016 | ||
| ALPL | alkaline phosphatase, liver/bone/kidney | 0.016 | ||
| SERTAD2 | SERTA domain containing 2 | 0.016 | ||
| AMBP | alpha-1-microglobulin/bikunin precursor | 0.016 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.016 | ||
| RAX | retina and anterior neural fold homeobox | 0.016 | ||
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.016 | ||
| SCOC | short coiled-coil protein | 0.016 | ||
| MAP2 | microtubule-associated protein 2 | 0.016 | ||
| RCOR1 | REST corepressor 1 | 0.016 | ||
| SCRT1 | scratch homolog 1, zinc finger protein (Drosophila) | 0.016 | ||
| BMP4 | bone morphogenetic protein 4 | 0.016 | Human | |
| ALDH1L1 | aldehyde dehydrogenase 1 family, member L1 | 0.016 | ||
| CTBS | chitobiase, di-N-acetyl- | 0.016 | ||
| RPS6KA5 | ribosomal protein S6 kinase, 90kDa, polypeptide 5 | 0.016 | ||
| CYB5A | cytochrome b5 type A (microsomal) | 0.016 | ||
| REG3A | regenerating islet-derived 3 alpha | 0.016 | ||
| NUPR1 | nuclear protein, transcriptional regulator, 1 | 0.016 | ||
| PCK1 | phosphoenolpyruvate carboxykinase 1 (soluble) | 0.016 | ||
| ESR2 | estrogen receptor 2 (ER beta) | 0.015 | ||
| MTTP | microsomal triglyceride transfer protein | 0.015 | ||
| SLC17A3 | solute carrier family 17 (sodium phosphate), member 3 | 0.015 | ||
| GRIK3 | glutamate receptor, ionotropic, kainate 3 | 0.015 | ||
| PTPRE | protein tyrosine phosphatase, receptor type, E | 0.015 | ||
| ALDH3B2 | aldehyde dehydrogenase 3 family, member B2 | 0.015 | ||
| SERPINA7 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 | 0.015 | ||
| IL8 | interleukin 8 | 0.015 | ||
| HS3ST2 | heparan sulfate (glucosamine) 3-O-sulfotransferase 2 | 0.015 | ||
| COL9A3 | collagen, type IX, alpha 3 | 0.015 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.015 | ||
| LY6D | lymphocyte antigen 6 complex, locus D | 0.015 | ||
| RARG | retinoic acid receptor, gamma | 0.015 | ||
| HRH3 | histamine receptor H3 | 0.015 | ||
| NPPC | natriuretic peptide C | 0.015 | ||
| CYP26A1 | cytochrome P450, family 26, subfamily A, polypeptide 1 | 0.015 | ||
| POU3F1 | POU class 3 homeobox 1 | 0.015 | ||
| GC | group-specific component (vitamin D binding protein) | 0.015 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.015 | ||
| TALDO1 | transaldolase 1 | 0.015 | ||
| FOXF1 | forkhead box F1 | 0.015 | ||
| NRIP1 | nuclear receptor interacting protein 1 | 0.015 | ||
| FMO3 | flavin containing monooxygenase 3 | 0.015 | ||
| TNMD | tenomodulin | 0.015 | ||
| CREBL2 | cAMP responsive element binding protein-like 2 | 0.015 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.015 | ||
| PGR | progesterone receptor | 0.015 | ||
| AFM | afamin | 0.015 | ||
| ABCC3 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 | 0.015 | ||
| PKP1 | plakophilin 1 (ectodermal dysplasia/skin fragility syndrome) | 0.015 | ||
| CXCL14 | chemokine (C-X-C motif) ligand 14 | 0.015 | ||
| ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | 0.015 | ||
| RGN | regucalcin (senescence marker protein-30) | 0.015 | ||
| SOX21 | SRY (sex determining region Y)-box 21 | 0.015 | ||
| NRP1 | neuropilin 1 | 0.015 | ||
| RASGRF1 | Ras protein-specific guanine nucleotide-releasing factor 1 | 0.015 | ||
| CALCA | calcitonin-related polypeptide alpha | 0.015 | ||
| CYP2B6 | cytochrome P450, family 2, subfamily B, polypeptide 6 | 0.015 | ||
| HOXD10 | homeobox D10 | 0.015 | ||
| NFYA | nuclear transcription factor Y, alpha | 0.015 | ||
| HS3ST6 | heparan sulfate (glucosamine) 3-O-sulfotransferase 6 | 0.015 | ||
| ANXA13 | annexin A13 | 0.015 | ||
| MYO7A | myosin VIIA | 0.014 | ||
| HSD11B2 | hydroxysteroid (11-beta) dehydrogenase 2 | 0.014 | Human | |
| ACE2 | angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 | 0.014 | ||
| PADI3 | peptidyl arginine deiminase, type III | 0.014 | ||
| AOX1 | aldehyde oxidase 1 | 0.014 | ||
| CYP2C8 | cytochrome P450, family 2, subfamily C, polypeptide 8 | 0.014 | ||
| TMEM173 | transmembrane protein 173 | 0.014 | ||
| SIX2 | SIX homeobox 2 | 0.014 | ||
| WNT10B | wingless-type MMTV integration site family, member 10B | 0.014 | Human | |
| CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.014 | ||
| CACNA1G | calcium channel, voltage-dependent, T type, alpha 1G subunit | 0.014 | Human | |
| CDHR5 | cadherin-related family member 5 | 0.014 | ||
| FEV | FEV (ETS oncogene family) | 0.014 | ||
| LHX1 | LIM homeobox 1 | 0.014 | ||
| TICAM2 | toll-like receptor adaptor molecule 2 | 0.014 | ||
| PDX1 | pancreatic and duodenal homeobox 1 | 0.014 | ||
| PTMS | parathymosin | 0.014 | ||
| BDH2 | 3-hydroxybutyrate dehydrogenase, type 2 | 0.014 | ||
| LEPROT | leptin receptor overlapping transcript | 0.014 | ||
| ABCC6 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 | 0.014 | ||
| C6 | complement component 6 | 0.014 | ||
| HCRTR1 | hypocretin (orexin) receptor 1 | 0.014 | ||
| NKD1 | naked cuticle homolog 1 (Drosophila) | 0.014 | ||
| REG1B | regenerating islet-derived 1 beta | 0.014 | ||
| TOB1 | transducer of ERBB2, 1 | 0.014 | ||
| ACAA1 | acetyl-CoA acyltransferase 1 | 0.014 | ||
| HEXB | hexosaminidase B (beta polypeptide) | 0.014 | ||
| BAAT | bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) | 0.014 | ||
| SLC18A3 | solute carrier family 18 (vesicular acetylcholine), member 3 | 0.014 | ||
| SLC22A1 | solute carrier family 22 (organic cation transporter), member 1 | 0.014 | ||
| PAX7 | paired box 7 | 0.013 | ||
| RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.013 | ||
| KLK10 | kallikrein-related peptidase 10 | 0.013 | ||
| CDK12 | cyclin-dependent kinase 12 | 0.013 | ||
| HOXA11 | homeobox A11 | 0.013 | ||
| C1QL1 | complement component 1, q subcomponent-like 1 | 0.013 | ||
| PAEP | progestagen-associated endometrial protein | 0.013 | ||
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.013 | Rat | |
| PITX3 | paired-like homeodomain 3 | 0.013 | ||
| UGT2B10 | UDP glucuronosyltransferase 2 family, polypeptide B10 | 0.013 | Human | |
| BCKDHB | branched chain keto acid dehydrogenase E1, beta polypeptide | 0.013 | ||
| APOC4 | apolipoprotein C-IV | 0.013 | ||
| CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 | 0.013 | ||
| TACR1 | tachykinin receptor 1 | 0.013 | ||
| NNAT | neuronatin | 0.013 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.013 | ||
| HMX1 | H6 family homeobox 1 | 0.013 | ||
| GDNF | glial cell derived neurotrophic factor | 0.013 | ||
| DUOX1 | dual oxidase 1 | 0.013 | ||
| CRABP1 | cellular retinoic acid binding protein 1 | 0.013 | ||
| ARHGAP29 | Rho GTPase activating protein 29 | 0.013 | ||
| SLC22A13 | solute carrier family 22 (organic anion transporter), member 13 | 0.013 | ||
| PCDH1 | protocadherin 1 | 0.013 | ||
| FGL1 | fibrinogen-like 1 | 0.013 | ||
| F11 | coagulation factor XI | 0.013 | ||
| PPARG | peroxisome proliferator-activated receptor gamma | 0.013 | ||
| RPS27L | ribosomal protein S27-like | 0.013 | ||
| AIPL1 | aryl hydrocarbon receptor interacting protein-like 1 | 0.013 | ||
| RPAIN | RPA interacting protein | 0.013 | ||
| ACAA2 | acetyl-CoA acyltransferase 2 | 0.013 | ||
| CDK8 | cyclin-dependent kinase 8 | 0.013 | ||
| ALDH3A1 | aldehyde dehydrogenase 3 family, member A1 | 0.013 | ||
| LYNX1 | Ly6/neurotoxin 1 | 0.013 | ||
| CCL16 | chemokine (C-C motif) ligand 16 | 0.013 | ||
| JPH3 | junctophilin 3 | 0.013 | ||
| LBX1 | ladybird homeobox 1 | 0.013 | ||
| EP300 | E1A binding protein p300 | 0.013 | ||
| METTL7A | methyltransferase like 7A | 0.013 | ||
| KCNK15 | potassium channel, subfamily K, member 15 | 0.013 | ||
| ENOX1 | ecto-NOX disulfide-thiol exchanger 1 | 0.013 | ||
| CDO1 | cysteine dioxygenase, type I | 0.013 | ||
| PAX2 | paired box 2 | 0.013 | ||
| GAGE3 | G antigen 3 | 0.013 | ||
| MASP2 | mannan-binding lectin serine peptidase 2 | 0.013 | ||
| PCK2 | phosphoenolpyruvate carboxykinase 2 (mitochondrial) | 0.013 | ||
| BMP2 | bone morphogenetic protein 2 | 0.013 | ||
| IRS2 | insulin receptor substrate 2 | 0.013 | ||
| UNC93A | unc-93 homolog A (C. elegans) | 0.013 | ||
| LIPC | lipase, hepatic | 0.013 | ||
| FGFR2 | fibroblast growth factor receptor 2 | 0.012 | ||
| EPHX1 | epoxide hydrolase 1, microsomal (xenobiotic) | 0.012 | ||
| AGXT | alanine-glyoxylate aminotransferase | 0.012 | ||
| ITIH2 | inter-alpha (globulin) inhibitor H2 | 0.012 | ||
| EPHB2 | EPH receptor B2 | 0.012 | ||
| YY1 | YY1 transcription factor | 0.012 | ||
| C8B | complement component 8, beta polypeptide | 0.012 | ||
| FOXB1 | forkhead box B1 | 0.012 | ||
| HABP2 | hyaluronan binding protein 2 | 0.012 | ||
| DUSP9 | dual specificity phosphatase 9 | 0.012 | ||
| GAL | galanin prepropeptide | 0.012 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.012 | ||
| FST | follistatin | 0.012 | ||
| KLK7 | kallikrein-related peptidase 7 | 0.012 | ||
| BEST2 | bestrophin 2 | 0.012 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.012 | ||
| CYP4F2 | cytochrome P450, family 4, subfamily F, polypeptide 2 | 0.012 | ||
| AHSG | alpha-2-HS-glycoprotein | 0.012 | ||
| CYP2C19 | cytochrome P450, family 2, subfamily C, polypeptide 19 | 0.012 | ||
| C4BPB | complement component 4 binding protein, beta | 0.012 | ||
| WNT7A | wingless-type MMTV integration site family, member 7A | 0.012 | Human | |
| LECT2 | leukocyte cell-derived chemotaxin 2 | 0.012 | ||
| MMP25 | matrix metallopeptidase 25 | 0.012 | ||
| CCNL1 | cyclin L1 | 0.012 | ||
| KRT4 | keratin 4 | 0.012 | ||
| PNLIP | pancreatic lipase | 0.012 | ||
| TMPRSS2 | transmembrane protease, serine 2 | 0.012 | ||
| GH2 | growth hormone 2 | 0.012 | ||
| GNL3L | guanine nucleotide binding protein-like 3 (nucleolar)-like | 0.012 | ||
| HOXD11 | homeobox D11 | 0.012 | ||
| HAVCR1 | hepatitis A virus cellular receptor 1 | 0.012 | ||
| SHANK2 | SH3 and multiple ankyrin repeat domains 2 | 0.012 | ||
| CES1 | carboxylesterase 1 | 0.012 | ||
| CRYL1 | crystallin, lambda 1 | 0.012 | ||
| SOSTDC1 | sclerostin domain containing 1 | 0.012 | ||
| PRRX2 | paired related homeobox 2 | 0.012 | ||
| DLX5 | distal-less homeobox 5 | 0.012 | ||
| F9 | coagulation factor IX | 0.012 | ||
| NPAS1 | neuronal PAS domain protein 1 | 0.012 | ||
| KCND3 | potassium voltage-gated channel, Shal-related subfamily, member 3 | 0.012 | ||
| HADHB | hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit | 0.012 | ||
| GSTA3 | glutathione S-transferase alpha 3 | 0.012 | ||
| ARSE | arylsulfatase E (chondrodysplasia punctata 1) | 0.012 | ||
| WT1 | Wilms tumor 1 | 0.012 | ||
| LRP2 | low density lipoprotein receptor-related protein 2 | 0.012 | ||
| REG1A | regenerating islet-derived 1 alpha | 0.012 | ||
| CDKN2B | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | 0.012 | ||
| FCHO2 | FCH domain only 2 | 0.012 | ||
| SULT2A1 | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | 0.012 | Human | |
| HOXB8 | homeobox B8 | 0.012 | ||
| CYP11B2 | cytochrome P450, family 11, subfamily B, polypeptide 2 | 0.012 | ||
| SYT12 | synaptotagmin XII | 0.012 | ||
| SARDH | sarcosine dehydrogenase | 0.012 | ||
| LOR | loricrin | 0.012 | ||
| IGF2 | insulin-like growth factor 2 (somatomedin A) | 0.012 | ||
| C9 | complement component 9 | 0.012 | ||
| TCF21 | transcription factor 21 | 0.012 | ||
| KCNJ15 | potassium inwardly-rectifying channel, subfamily J, member 15 | 0.012 | ||
| HOXC8 | homeobox C8 | 0.012 | ||
| HSD17B2 | hydroxysteroid (17-beta) dehydrogenase 2 | 0.012 | Human Rat | |
| TRAPPC6A | trafficking protein particle complex 6A | 0.012 | ||
| A1CF | APOBEC1 complementation factor | 0.012 | ||
| BARX2 | BARX homeobox 2 | 0.012 | ||
| IRS1 | insulin receptor substrate 1 | 0.012 | ||
| BMP8A | bone morphogenetic protein 8a | 0.012 | Human | |
| COL13A1 | collagen, type XIII, alpha 1 | 0.012 | ||
| TGFA | transforming growth factor, alpha | 0.012 | ||
| STAP2 | signal transducing adaptor family member 2 | 0.012 | ||
| ART4 | ADP-ribosyltransferase 4 (Dombrock blood group) | 0.012 | ||
| PLG | plasminogen | 0.012 | ||
| ACAN | aggrecan | 0.011 | ||
| AGA | aspartylglucosaminidase | 0.011 | ||
| PIK3C2G | phosphoinositide-3-kinase, class 2, gamma polypeptide | 0.011 | ||
| CCNG1 | cyclin G1 | 0.011 | ||
| EPHA1 | EPH receptor A1 | 0.011 | ||
| ADH4 | alcohol dehydrogenase 4 (class II), pi polypeptide | 0.011 | ||
| SLC9A3 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 | 0.011 | ||
| ENTPD2 | ectonucleoside triphosphate diphosphohydrolase 2 | 0.011 | ||
| SFRP5 | secreted frizzled-related protein 5 | 0.011 | ||
| CRLF1 | cytokine receptor-like factor 1 | 0.011 | ||
| SLC26A3 | solute carrier family 26, member 3 | 0.011 | ||
| RARRES1 | retinoic acid receptor responder (tazarotene induced) 1 | 0.011 | ||
| PTHLH | parathyroid hormone-like hormone | 0.011 | ||
| ALX4 | ALX homeobox 4 | 0.011 | ||
| GAD2 | glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) | 0.011 | ||
| SLC6A2 | solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 | 0.011 | ||
| RET | ret proto-oncogene | 0.011 | ||
| GPC3 | glypican 3 | 0.011 | ||
| LAPTM4A | lysosomal protein transmembrane 4 alpha | 0.011 | ||
| GADD45GIP1 | growth arrest and DNA-damage-inducible, gamma interacting protein 1 | 0.011 | ||
| KLK8 | kallikrein-related peptidase 8 | 0.011 | ||
| ABCC8 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | 0.011 | ||
| PVRL1 | poliovirus receptor-related 1 (herpesvirus entry mediator C) | 0.011 | ||
| MAN1A1 | mannosidase, alpha, class 1A, member 1 | 0.011 | ||
| CRCT1 | cysteine-rich C-terminal 1 | 0.011 | ||
| GCDH | glutaryl-CoA dehydrogenase | 0.011 | ||
| FZD8 | frizzled homolog 8 (Drosophila) | 0.011 | ||
| TLX3 | T-cell leukemia homeobox 3 | 0.011 | ||
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.011 | ||
| SLC6A12 | solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 | 0.011 | ||
| GPX3 | glutathione peroxidase 3 (plasma) | 0.011 | ||
| GSTM4 | glutathione S-transferase mu 4 | 0.011 | ||
| CYP7B1 | cytochrome P450, family 7, subfamily B, polypeptide 1 | 0.011 | ||
| HAO1 | hydroxyacid oxidase (glycolate oxidase) 1 | 0.011 | ||
| TRIM29 | tripartite motif containing 29 | 0.011 | ||
| GPR143 | G protein-coupled receptor 143 | 0.011 | ||
| PIPOX | pipecolic acid oxidase | 0.011 | ||
| AKR1D1 | aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase) | 0.011 | ||
| MT1A | metallothionein 1A | 0.011 | ||
| PTH1R | parathyroid hormone 1 receptor | 0.011 | ||
| DAB1 | disabled homolog 1 (Drosophila) | 0.011 | ||
| KCNQ2 | potassium voltage-gated channel, KQT-like subfamily, member 2 | 0.011 | ||
| TMEM30B | transmembrane protein 30B | 0.011 | ||
| PDE6A | phosphodiesterase 6A, cGMP-specific, rod, alpha | 0.011 | ||
| KCNK9 | potassium channel, subfamily K, member 9 | 0.011 | ||
| IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.011 | ||
| HAL | histidine ammonia-lyase | 0.011 | ||
| S100A2 | S100 calcium binding protein A2 | 0.011 | ||
| HAO2 | hydroxyacid oxidase 2 (long chain) | 0.011 | ||
| AQP9 | aquaporin 9 | 0.011 | ||
| BCL6 | B-cell CLL/lymphoma 6 | 0.011 | ||
| NKX3-1 | NK3 homeobox 1 | 0.011 | ||
| SOAT2 | sterol O-acyltransferase 2 | 0.011 | ||
| IRS4 | insulin receptor substrate 4 | 0.011 | ||
| SLC13A3 | solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 | 0.011 | ||
| BCL11A | B-cell CLL/lymphoma 11A (zinc finger protein) | 0.011 | ||
| HTR1A | 5-hydroxytryptamine (serotonin) receptor 1A | 0.011 | ||
| CDH6 | cadherin 6, type 2, K-cadherin (fetal kidney) | 0.011 | ||
| PITX1 | paired-like homeodomain 1 | 0.011 | ||
| KCNC3 | potassium voltage-gated channel, Shaw-related subfamily, member 3 | 0.011 | ||
| BMP10 | bone morphogenetic protein 10 | 0.011 | Human | |
| LHX2 | LIM homeobox 2 | 0.011 | ||
| THRB | thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian) | 0.011 | ||
| RASSF5 | Ras association (RalGDS/AF-6) domain family member 5 | 0.011 | ||
| MED25 | mediator complex subunit 25 | 0.011 | ||
| AHNAK | AHNAK nucleoprotein | 0.011 | ||
| HGD | homogentisate 1,2-dioxygenase | 0.011 | ||
| UGT2B7 | UDP glucuronosyltransferase 2 family, polypeptide B7 | 0.011 | ||
| RAPGEF6 | Rap guanine nucleotide exchange factor (GEF) 6 | 0.011 | ||
| FOXF2 | forkhead box F2 | 0.011 | ||
| SGK1 | serum/glucocorticoid regulated kinase 1 | 0.011 | ||
| SH2B1 | SH2B adaptor protein 1 | 0.011 | ||
| PIM1 | pim-1 oncogene | 0.011 | ||
| ALOXE3 | arachidonate lipoxygenase 3 | 0.011 | ||
| CLCA2 | chloride channel accessory 2 | 0.011 | ||
| SPRR2B | small proline-rich protein 2B | 0.011 | ||
| ZMYND11 | zinc finger, MYND-type containing 11 | 0.011 | ||
| C14orf1 | chromosome 14 open reading frame 1 | 0.011 | ||
| ABCG5 | ATP-binding cassette, sub-family G (WHITE), member 5 | 0.011 | ||
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.010 | ||
| LXN | latexin | 0.010 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.010 | ||
| EREG | epiregulin | 0.010 | ||
| APOM | apolipoprotein M | 0.010 | ||
| HUNK | hormonally up-regulated Neu-associated kinase | 0.010 | ||
| APOF | apolipoprotein F | 0.010 | ||
| CPB2 | carboxypeptidase B2 (plasma) | 0.010 | ||
| PAPSS2 | 3'-phosphoadenosine 5'-phosphosulfate synthase 2 | 0.010 | ||
| GAS1 | growth arrest-specific 1 | 0.010 | ||
| FMO4 | flavin containing monooxygenase 4 | 0.010 | ||
| SLC1A6 | solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 | 0.010 | ||
| SERPIND1 | serpin peptidase inhibitor, clade D (heparin cofactor), member 1 | 0.010 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.010 | ||
| CYP4F12 | cytochrome P450, family 4, subfamily F, polypeptide 12 | 0.010 | ||
| HAAO | 3-hydroxyanthranilate 3,4-dioxygenase | 0.010 | ||
| KREMEN2 | kringle containing transmembrane protein 2 | 0.010 | ||
| KCNMB2 | potassium large conductance calcium-activated channel, subfamily M, beta member 2 | 0.010 | ||
| ACPP | acid phosphatase, prostate | 0.010 | ||
| ACSM3 | acyl-CoA synthetase medium-chain family member 3 | 0.010 | ||
| ARTN | artemin | 0.010 | ||
| NXPH4 | neurexophilin 4 | 0.010 | ||
| UPK1B | uroplakin 1B | 0.010 | ||
| WNT2B | wingless-type MMTV integration site family, member 2B | 0.010 | Human | |
| PLEKHG6 | pleckstrin homology domain containing, family G (with RhoGef domain) member 6 | 0.010 | ||
| DKK1 | dickkopf homolog 1 (Xenopus laevis) | 0.010 | ||
| MIA2 | melanoma inhibitory activity 2 | 0.010 | ||
| PAX8 | paired box 8 | 0.010 | ||
| UTF1 | undifferentiated embryonic cell transcription factor 1 | 0.010 | ||
| ARL4D | ADP-ribosylation factor-like 4D | 0.010 | ||
| CAPN6 | calpain 6 | 0.010 | ||
| WNT5B | wingless-type MMTV integration site family, member 5B | 0.010 | Human | |
| IVL | involucrin | 0.010 | ||
| CLEC4M | C-type lectin domain family 4, member M | 0.010 | ||
| DMRT3 | doublesex and mab-3 related transcription factor 3 | 0.010 | ||
| EXTL1 | exostoses (multiple)-like 1 | 0.010 | ||
| NFIL3 | nuclear factor, interleukin 3 regulated | 0.010 | ||
| EPHX2 | epoxide hydrolase 2, cytoplasmic | 0.010 | ||
| ALOX12B | arachidonate 12-lipoxygenase, 12R type | 0.010 | ||
| FETUB | fetuin B | 0.010 | ||
| HES2 | hairy and enhancer of split 2 (Drosophila) | 0.010 | ||
| TNK1 | tyrosine kinase, non-receptor, 1 | 0.010 | ||
| IL11 | interleukin 11 | 0.010 | ||
| A4GALT | alpha 1,4-galactosyltransferase | 0.010 | ||
| GSTA1 | glutathione S-transferase alpha 1 | 0.010 | ||
| LHB | luteinizing hormone beta polypeptide | 0.010 | ||
| VNN1 | vanin 1 | 0.010 | ||
| PRL | prolactin | 0.010 | ||
| DRD4 | dopamine receptor D4 | 0.010 | ||
| SLC1A7 | solute carrier family 1 (glutamate transporter), member 7 | 0.010 | ||
| GALR2 | galanin receptor 2 | 0.010 | ||
| DSG1 | desmoglein 1 | 0.010 | ||
| RARRES2 | retinoic acid receptor responder (tazarotene induced) 2 | 0.010 |